MSD

MK6482

Biodrugs/ Drugs
Cancer
MK-6482 Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL) and Pancreatic Neuroendocrine Tumor (pNET)
2Phase II in Spain, 1Phase I